2/2/2010

U.K. scientists found that almost half of 13 patients with complex regional pain syndrome experienced pain relief for an average of five weeks after receiving a low-dose transfusion of intravenous immunoglobulin, a human blood antibody. "The discovery is expected to have a real impact on the treatment of other unexplained chronic pain conditions," the lead researcher said.

Related Summaries